ASPS President's Panel Saturday, October 17 Sat, Oct 17 2:00-3:00 p.m. CDT

Drawing on his experience leading the FDA, Dr. Makary will provide a unique perspective from inside the agency on the regulatory, scientific, and policy forces shaping the future of medical innovation. He will explore how emerging technologies are evaluated, how evidence informs regulatory decision making, and how we can accelerate meaningful innovation while protecting patient safety and maintaining public trust.

Dr. Basu will then lead a candid conversation with Dr. Makary about what these changes mean specifically for plastic surgery. Together, they will explore the rapidly evolving landscape of medical devices, artificial intelligence, regenerative medicine, therapeutics, and other emerging technologies; the changing relationship between regulators, physicians, researchers, professional societies, and industry; and how plastic surgeons can play a meaningful role in shaping responsible innovation rather than simply responding to it.

This Presidential session offers a rare opportunity to look beyond today's regulatory environment and consider what comes next for our specialty, our patients, and the future of surgical innovation.

Upon completion of this session, participants should be able to:

1. Describe how scientific evidence, emerging technologies, and policy considerations inform FDA regulatory decision making and the evaluation of medical innovation.
2. Assess how evolving regulatory approaches to medical devices, artificial intelligence, regenerative medicine, therapeutics, and other emerging technologies may affect plastic surgery practice and patient care.
3. Identify opportunities for plastic surgeons and professional societies to engage with regulators, researchers, and industry to advance responsible innovation while protecting patient safety and maintaining public trust.

For more information, please visit https://www.plasticsurgerythemeeting.com/programming/asps-presidents-panel